Results 51 to 60 of about 237 (77)

Activity of combinations of bactericidal and bacteriostatic compounds in <i>Mycobacterium abscessus</i>-infected mice: an overview. [PDF]

Front Microbiol
Lanni A, Iona E, Fattorini L, Giannoni F, Iacobino A.   +4 more
europepmc   +1 more source

Treatment for non-tuberculous mycobacteria: challenges and prospects. [PDF]

Front Microbiol
Conyers LE, Saunders BM.
europepmc   +1 more source

We Are Underprepared for Bedaquiline Resistance: A Call for Clinical and Programmatic Readiness. [PDF]

Clin Infect Dis
Cross GB, Walker HN, Hasan T, Berry C.
europepmc   +1 more source

The Structure, Properties, and Clinical Utility of Contezolid for Antituberculosis: A Narrative Review. [PDF]

Infect Dis Ther
Chen T, Li W, Shen F, Nie W, Wu F.
europepmc   +1 more source

Facile Synthesis of Oxazolidinones as Potential Antibacterial Agents. [PDF]

ChemistryOpen
Els SP, Govender KB, Sokhela MK, Bhatt N, Reddy N, Kruger HG, Arvidsson PI, Gunosewoyo H, Govender T, Naicker T.   +9 more
europepmc   +1 more source

Bridging science and policy in tuberculosis treatment through innovations in precision medicine, drug development, and cohort research: a narrative review. [PDF]

Ewha Med J
Min J, Andrade BB, Kim JS, Jeong Y.
europepmc   +1 more source

Susceptibility of <i>Staphylococcus aureus</i> Strains Isolated from Blood Cultures Between 2024 and 2025: A Single-Center Study. [PDF]

Antibiotics (Basel)
Birlutiu V, Ciprian Ion O, Birlutiu RM.
europepmc   +1 more source

[Research and International Cooperation for Shortening the Treatment Duration of Tuberculosis]. [PDF]

Jugan Geongang Gwa Jilbyeong
Jeon SM, Kim TH, Lee S, Kim S.
europepmc   +1 more source

[Research Trends in Nontuberculous Mycobacterial Treatment]. [PDF]

Jugan Geongang Gwa Jilbyeong
Park S, Choi S, Jeon SM, Kim S.
europepmc   +1 more source